Quell Therapeutics in a £19.9m strategic equity round with AstraZeneca.
21 June 2023
21 June 2023
Total investments received (USD): 266.17m
Round value (USD): 25.13m
Round investors:
AstraZeneca
Company: Quell Therapeutics
Related deals
Apollo Therapeutics raised $33.5m in an extended Series C funding led by Patient Square Capital, joined by M&G and Rock Springs Capital.
Investments
03 December 2023
ViaNautis to raise £20M series A with UCB Ventures, BGF Ventures, 4BIO Capital
Investments
10 November 2023
Sitryx Therapeutics in a £32M series A led by Oxford Science Enterprises
Investments
01 September 2023
Lightcast Discovery raised $49M in Series B led by M Ventures, joined by ARCH Venture, Illumina Ventures, OMX Ventures, +ND Capital and Longwall Ventures.
Investments
12 August 2023
Theolytics in a £22.1M equity round with Taiho Ventures, Oxford Science Enterprises, M Ventures and Epidarex Capital
Investments
05 August 2023
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Italy
Portugal
Spain